BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 35480)

  • 1. [The use of bromperidol in an open study].
    Hucker H
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():53-61. PubMed ID: 35480
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of diagnosis, hospital and sex on the effects of bromperidol].
    Woggon B; Fleischhauer J; Widmer A
    Int Pharmacopsychiatry; 1979; 14(4):213-27. PubMed ID: 42629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Introductory words to the exchange of results on the clinical effects of bromperidol. Results of open and double blind research].
    Bures E; Pöldinger W
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():45-52. PubMed ID: 35479
    [No Abstract]   [Full Text] [Related]  

  • 4. [Report on an open investigation on bromperidol, a neuroleptic of the butyrophenone series].
    Fleischhauer J
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():30-7. PubMed ID: 35476
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of a double blind study with bromperidol and perphenazine].
    Woggon B
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():62-71. PubMed ID: 35481
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tolerance of bromperidol in long term application].
    Scelovic B
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():38-40. PubMed ID: 35477
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind- evaluation of bromperidol versus haloperidol treatment in chronic psychotic patients.
    Malfroid M; Hens L; Roosen P; Dom R
    Acta Psychiatr Belg; 1978; 78(1):147-54. PubMed ID: 347877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoridazine in neuroleptic-resistant psychoses.
    Osser DN; Albert LG; Figueiredo S; O'Connor H; Barden Y; Carmichael WG
    J Clin Psychopharmacol; 1991 Oct; 11(5):328-30. PubMed ID: 1684976
    [No Abstract]   [Full Text] [Related]  

  • 9. [New "atypical" neuroleptics -- the emperor's new clothes?].
    Dose M
    Psychiatr Prax; 2003 Jan; 30(1):1-3. PubMed ID: 12524575
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems of use trials of long-acting tranquilizers in acute psychiatric syndromes].
    Ropert R; Lévy L; Ropert M
    Ann Med Psychol (Paris); 1973 Feb; 2(2):259-67. PubMed ID: 4147917
    [No Abstract]   [Full Text] [Related]  

  • 11. Bupropion in the long-term treatment of cyclic mood disorders: mood stabilizing effects.
    Wright G; Galloway L; Kim J; Dalton M; Miller L; Stern W
    J Clin Psychiatry; 1985 Jan; 46(1):22-5. PubMed ID: 2856918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected.
    Agid O; Kapur S; Arenovich T; Zipursky RB
    Arch Gen Psychiatry; 2003 Dec; 60(12):1228-35. PubMed ID: 14662555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bromperidol decanoate in the residual phase of schizophrenia].
    Smeraldi E; Cocconcelli C; Canova L; Faravelli C; Marchetti FP; Mariani G; Rapisarda V
    Minerva Psichiatr; 1996 Mar; 37(1):39-44. PubMed ID: 8926856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary note on the antipsychotic efficacy of bromperidol.
    Bataille M
    Acta Psychiatr Belg; 1978; 78(1):173-9. PubMed ID: 347879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zuclopenthixol: a new generation of antipsychotic drugs. An open clinical trial.
    Matar AM; Abdel-Mawgoud M; Skov S
    J Clin Psychopharmacol; 1990 Aug; 10(4):283-6. PubMed ID: 1981068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroleptic potency of bromperidol].
    Kaumeier S; Haase HJ; Schwarz H; Gundel A; Linde OK; Maetz H; Scheel R; Stripf A; Stripf L
    Int Pharmacopsychiatry; 1978; 13 Suppl 1():41-4. PubMed ID: 35478
    [No Abstract]   [Full Text] [Related]  

  • 17. [Conditions for prolonged prescription of neuroleptics with reference to several clinical cases].
    Tholose A
    Ann Med Psychol (Paris); 1981; 139(8):894-9. PubMed ID: 6120672
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid tranquilization: the efficacy of oral concentrate.
    Dubin WR; Waxman HM; Weiss KJ; Ramchandani D; Tavani-Petrone C
    J Clin Psychiatry; 1985 Nov; 46(11):475-8. PubMed ID: 2865251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the efficacy of haloperidol decanoate].
    Alvarez JV; Li Gambi M
    Acta Psiquiatr Psicol Am Lat; 1986 Sep; 32(3):233-6. PubMed ID: 2884807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in refractory psychosis with dronabinol: four case reports.
    Schwarcz G; Karajgi B
    J Clin Psychiatry; 2010 Nov; 71(11):1552-3. PubMed ID: 21114952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.